C. Schalkwijk

发表

ACE‐inhibition modulates some endothelial functions in healthy subjects and in normotensive type 1 diabetic patients

A. Donker, C. Stehouwer, C. Schalkwijk, 2000, European journal of clinical investigation.

Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans

C. Stehouwer, C. Schalkwijk, D. Hansen, 2018, Scientific Reports.

Targeting hyperglycaemia with either metformin or repaglinide in non‐obese patients with type 2 diabetes: results from a randomized crossover trial

O. Pedersen, A. Vaag, H. Parving, 2007, Diabetes, obesity & metabolism.

Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes.

C. Schalkwijk, B. Thorsteinsson, C. Schalkwijk, 2010, European journal of endocrinology.

Serum sex hormone-binding globulin levels are reduced and inversely associated with intrahepatic lipid content and saturated fatty acid fraction in adult patients with glycogen storage disease type 1a

T. Derks, C. Schalkwijk, V. Schrauwen-Hinderling, 2022, Journal of Endocrinological Investigation.

ANTI‐HSP60 and ANTI‐HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study

G. Bruno, N. Chaturvedi, D. Witte, 2009, Journal of internal medicine.

Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes—the CORALL study

B. Wolffenbuttel, C. Schalkwijk, S. Simsek, 2012, Diabetic medicine : a journal of the British Diabetic Association.

Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina

Alan W. Stitt, C. Schalkwijk, R. Schlingemann, 2007, Diabetologia.

Angiotensin II blockade is associated with decreased plasma leukocyte adhesion molecule levels in diabetic nephropathy.

H. Parving, C. Stehouwer, C. Schalkwijk, 2000, Diabetes care.

Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries.

H. Parving, L. Tarnow, C. Stehouwer, 1999, Diabetes.

Distinct associations of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus.

A. Donker, C. Stehouwer, V. V. van Hinsbergh, 1998, Thrombosis and haemostasis.

Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women.

A. Hofman, J. Witteman, K. Polderman, 1999, Arteriosclerosis, thrombosis, and vascular biology.

BclI glucocorticoid receptor polymorphism is associated with greater body fatness: the Hoorn and CODAM studies.

G. Nijpels, L. T. ’t Hart, C. Stehouwer, 2013, The Journal of clinical endocrinology and metabolism.

Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3‐deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub‐study

H. Parving, C. Stehouwer, M. V. van Greevenbroek, 2020, Diabetic medicine : a journal of the British Diabetic Association.

Liraglutide treatment attenuates inflammation markers in the cardiac, cerebral and renal microvasculature in streptozotocin‐induced diabetic rats

S. Simsek, C. Schalkwijk, U. Baylan, 2022, European journal of clinical investigation.

Serum levels of autoantibodies against the angiotensin II type I receptor are not associated with serum dicarbonyl or AGE levels in patients with an aldosterone-producing adenoma

C. Schalkwijk, J. Scheijen, N. Hanssen, 2022, Journal of Human Hypertension.

In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans.

E. Giltay, C. Schalkwijk, H. Drexhage, 2000, The Journal of clinical endocrinology and metabolism.

Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans

C. Stehouwer, C. Schalkwijk, D. Hansen, 2018, Scientific Reports.

Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes—the EURODIAB Prospective Complications Study

N. Chaturvedi, M. Schram, C. Schalkwijk, 2005, Diabetologia.

Raloxifene, conjugated oestrogen and endothelial function in postmenopausal women

C. Stehouwer, C. Schalkwijk, E. J. Duschek, 2003, Journal of internal medicine.

Amadori‐albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients

N. Chaturvedi, C. Schalkwijk, V. V. van Hinsbergh, 2002, European journal of clinical investigation.

Up-regulation of the complement system in subcutaneous adipocytes from nonobese, hypertriglyceridemic subjects is associated with adipocyte insulin resistance.

C. Stehouwer, C. V. D. van der Kallen, C. Schalkwijk, 2012, The Journal of clinical endocrinology and metabolism.

Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: A randomized double‐blind placebo‐controlled trial

S. Eussen, N. Hanssen, C. Schalkwijk, 2023, Diabetes, obesity & metabolism.

Endothelial dysfunction is associated with a greater depressive symptom score in a general elderly population: the Hoorn Study

F. Pouwer, G. Nijpels, J. Dekker, 2013, Psychological Medicine.

Modulation of plasma endothelin levels by the menstrual cycle.

K. Polderman, C. Stehouwer, L. Gooren, 2000, Metabolism: clinical and experimental.

Low‐grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study

E. Feskens, C. V. D. van der Kallen, M. V. van Greevenbroek, 2009, European journal of clinical investigation.

Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial

H. Parving, C. Stehouwer, C. Schalkwijk, 2010, Diabetologia.

Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study

H. Parving, L. Tarnow, C. Stehouwer, 2017, Cardiovascular Diabetology.

Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study

H. Parving, L. Tarnow, P. Rossing, 2012, Diabetologia.

Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.

C. Schalkwijk, J. V. D. van der Meer, M. van Deuren, 1995, Blood.

A SNP panel for identification of DNA and RNA specimens

J. V. van Meurs, M. Bonder, A. Zhernakova, 2018, BMC Genomics.